Sort
261,768 grants matching “gene therapy”
Stalled replication fork repair in cancer predisposition and cancertherapy
$1,037,400Ralph Scully · Beth Israel Deaconess Medical Center · R35 · FY2025 · CA
Reading mitochondrial apoptotic signaling to identify active cancer therapeutics
$1,037,388Anthony G Letai · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,037,336Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Advancing a Candidate Polyclonal Antibody Therapy for Hantavirus Disease
$1,037,264Jay Williams Hooper · Geneva Foundation · R01 · FY2017 · AI
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$1,037,023William C Hahn · Dana-Farber Cancer Inst · U01 · FY2023 · CA
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$1,037,023William C Hahn · Dana-Farber Cancer Inst · U01 · FY2025 · CA
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$1,037,023William C Hahn · Dana-Farber Cancer Inst · U01 · FY2022 · CA
San Antonio Claude D. Pepper Older Americans Independence Center
$1,036,987Nicolas Musi · University Of Texas Hlth Science Center · P30 · FY2018 · AG
MARC U*STAR Program at UMBC
$1,036,897Lasse A Lindahl · University Of Maryland Baltimore County · T34 · FY2010 · GM
Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection
$1,036,895Sergei V Kotenko · Rbhs-New Jersey Medical School · R01 · FY2013 · AI
Receptor Mediated Erythropoietin Metabolic Response
$1,036,882Constance Noguchi · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease
$1,036,834Aaron D. Gitler · Stanford University · R35 · FY2021 · NS
CENTER FOR AIDS RESEARCH
$1,036,824University Of California San Diego · P30 · FY2000 · AI
Development of Recombinant Toxins to Treat Hematologic Malignancies
$1,036,808Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Biology of memory
$1,036,800Ronald L Davis · Scripps Florida · R35 · FY2020 · NS
Genomics of Antibiotic Resistance in Bacterial Pathogens
$1,036,666Derrick Fouts · J. Craig Venter Institute, Inc. · U19 · FY2018 · AI
Selective targeting of high affinity alpha4 integrins as a safe treatment strategy for IBD
$1,036,641Darren G Woodside · Aviara Pharmaceuticals, Inc. · R42 · FY2023 · DK
TOWARDS A REFINED MOLECULAR RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOM
$1,036,498Walter John Curran · American College Of Radiology · RC2 · FY2009 · CA
Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1
$1,036,451Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Novel small-molecule therapies for CF
$1,036,332Alan S Verkman · University Of California, San Francisco · P30 · FY2009 · DK
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
$1,036,319Kiona Allen · Lurie Children'S Hospital Of Chicago · UH3 · FY2022 · HL
Role of Microglia somatic variants in Neurodegenerative diseases
$1,036,170Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2022 · NS
Role of Microglia somatic variants in Neurodegenerative diseases
$1,036,170Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2021 · NS
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant Infections
$1,036,121Victor Nizet · University Of California, San Diego · R01 · FY2011 · AI
Ultrasensitive Nanofluidic Devices for Genomic Analysis
$1,036,104Stephen R Quake · Stanford University · R01 · FY2007 · HG